CBP/p300 and muscle differentiation: No HAT, no muscle

EMBO Journal

Volumn 20, Issue 23, 2001, Pages 6816-6825

  Polesskaya, A ^a   Naguibneva, I ^a   Fritsch, L ^a   Duquet, A ^a   Ait Si Ali, S ^a   Robin, P ^a   Vervisch, A ^b   Pritchard, L L ^a   Cole, P ^c   Harel Bellan, A ^a  

^a CNRS UPR 9079 Oncogenese Differenciation et Transduction du Signal   (France)

^b INSTITUT ANDRÉ LWOFF   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CREB binding protein (CBp); Histone acetyl transferase; MyoD; Myogenesis; p300

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME INHIBITOR; HISTONE ACETYLTRANSFERASE; MUTANT PROTEIN; MYOD PROTEIN; PROTEIN P300; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GCN5; TRANSCRIPTION FACTOR PCAF; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; E1A-ASSOCIATED P300 PROTEIN; GENES, DOMINANT; GENES, REPORTER; HISTONE ACETYLTRANSFERASES; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, FLUORESCENCE; MUSCLES; MUTATION; MYOGENIN; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE PROTEINS; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 17944373135     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.23.6816     Document Type: Article

References (60)

1. A rapid and sensitive assay for histone acetyl-transferase activity
2. 1/S transition
3. EIA-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
4. The CBP co-activator is a histone acetyltransferase
5. Special HATs for special occasions: Linking histone acetylation to chromatin assembly and gene activation
6. Muscle differentiation. Which myogenic factors make muscle?
7. Skeletal muscle development and the role of the myogenic regulatory factors
8. Role of CBP/P300 in nuclear receptor signaling
9. GCN5-related N-acetyltransferases: A structural overview
10. Association of p300 and CBP with simian virus 40 large T antigen
11. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation
12. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation programme
13. Mitogenic repression of myogenin autoregulation
14. Cell cycle dependent stable recruitment of a histone deacetylase correlates with histone H4 lysine 5 and 12 deacetylation on an E2F target promoter
15. CBP/p300 in cell growth, transformation and development
16. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
17. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
18. Rb function in cell-cycle regulation and apoptosis
19. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
20. Regulation of the levels of small heat-shock proteins during differentiation of C2C12 cells
21. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation
22. Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin
23. Spatially- and temporally-restricted expression of meltrin α (ADAM12) and β (ADAM19) in mouse embryo
24. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer
25. HATs off: Selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF
26. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases
27. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells
28. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
29. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation
30. Linking histone acetylation to transcriptional regulation
31. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity
32. 2 phases of the cell cycle
33. The transcriptional coactivators p300 and CBP are histone acetyltransferases
34. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: Implications for a dominant-negative mechanism
35. Mice homozygous for a truncated form of CREB binding protein exhibit defects in hematopoiesis and vasculoangiogenesis
36. Cip1 in muscle and other terminally differentiating cells
37. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
38. CREB-binding protein/p300 activates MyoD by acetylation
39. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300
40. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
41. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation
42. The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors
43. The MyoD family of transcription factors and skeletal myogenesis
44. MyoD or Myf-5 is required for the formation of skeletal muscle
45. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
46. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle programme
47. The PCAF acetylase complex as a potential tumor suppressor
48. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates
49. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation and suppress tumor cell growth
50. Steroid receptor coactivator-1 is a histone acetyltransferase
51. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus
52. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor
53. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes
54. Myogenin is required for late but not early aspects of myogenesis during mouse development
55. The MyoD family and myogenesis: Redundancy, networks and thresholds
56. Loss of gcn512 leads to increased apoptosis and mesodermal defects during mouse development
57. Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis
58. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
59. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
60. Human p300 protein is a coactivator for the transcription factor MyoD